[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Laser Defined Vision\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":58},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,37],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":36},"100643416","post-refractive-iol-outcomes-with-clareon-truplus-100643416",false,"NCT07610226","Post-refractive IOL Outcomes With Clareon TruPlus","Inclusion Criteria:\n\n* Willing and able to understand and sign informed consent.\n* Adult patients (\\>45 years old) undergoing age-related cataract surgery that previously had myopic corneal refractive surgery.\n* Dominant eye targeted for emmetropia, non-dominant eye may be targeted for ≤-0.75D (mini-monovision).\n* Best monocular corrected distance visual acuity expected to be 0.1 logMAR (Snellen 20\u002F25) or better in both eyes pre-operatively as determined by surgeon.\n* Normal ocular findings aside from cataract.\n\nExclusion Criteria:\n\n* Moderate-severe corneal pathology, irregular astigmatism, preexisting macular disease and other retinal degenerative diseases, diabetic retinopathy that is expected to cause future vision loss, glaucoma, severe dry eye disease, nystagmus, strabismus, zonular laxity or dehiscence, pseudoexfoliation.\n* Previous history of any ocular surgery, except for myopic LASIK or PRK.\n* Previous hyperopic refractive surgery.\n* Corneal HOA ≥1.0 µm (RMS) with OPD at 4mm scan.\n* Any active ocular infection or inflammation.","ALL","18 Years",{"count":18,"type":19},35,"ESTIMATED","OBSERVATIONAL","This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.",[23],"Cataract","RECRUITING","2026-06-10",{"date":27,"type":28},"2026-06-12","ACTUAL",{"date":30,"type":19},"2026-06-23",{"date":32,"type":19},"2027-06-23",{"name":34,"class":35},"Laser Defined Vision","OTHER",1,{"id":38,"slug":39,"hasResults":11,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":4,"eligibilityCriteria":43,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":44,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":46,"conditions":47,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":36},"100602764","clinical-evaluation-of-wavelight-plus-lasik-100602764","NCT07127757","Clinical Evaluation of WaveLight Plus LASIK","Clinical Evaluation of Visual Outcomes With the Wavelight Plus Excimer Laser in Normal and Dim Lighting","Inclusion Criteria:\n\n* Subject must be able to understand and sign an IRB approved Informed consent form\n* Willing and able to attend all scheduled study visits as required per protocol\n* Minimum of 18 years of age\n* Myopia up to -8.00 D, astigmatism up to -3.00 D, with SE more than -1.00D and up to -9.00D, based on Sightmap measured refraction\n* Best corrected photopic distance visual acuity of 20\u002F20-2 or better (≤ 0.04 logMAR)\n* Mesopic pupil size ≥ 4.5mm\n* Less than 0.75 D manifest refraction spherical equivalent difference between Sightmap refraction and subjective manifest refraction\n* Stable refraction (within ± 0.50 D) as determined by manifest refraction spherical equivalent for a minimum of 12 months prior to surgery, verified by consecutive subjective refractions or medical records or prescription history\n* If currently wearing contact lenses:\n\n  * Soft CTL wearers discontinue for minimum 3 days prior to first refraction\n  * RGP or toric soft CTL wearers discontinue for ≥2 weeks prior to first refraction\n\nExclusion Criteria:\n\n* Subjects who are pregnant or nursing\n* Acute or chronic disease or illness that would increase the operative risk or confound the outcomes of the study\n* Patients with flap complications\n* Systemic medications that may confound the outcome of the study or increase the risk to the subject.\n* Ocular condition (other than high myopia) that may predispose the subject to future complications, such as ectasia\n* History or evidence of active or inactive corneal disease (e.g., herpes simplex keratitis, herpes zoster keratitis, recurrent corneal erosion syndrome, corneal dystrophy)\n* Evidence of retinal vascular disease\n* Keratoconus or Keratoconus suspect\n* Glaucoma or glaucoma suspect by exam findings and\u002For family history\n* Previous intraocular or corneal surgery\n* Predicted residual stromal bed thickness \\\u003C 250 μm\n* Intended to have monovision treatment\n* Participation in other current clinical trials",{"count":45,"type":19},50,"This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and Low Luminance Questionnaire (LLQ-32) Questionnaire.",[48,49],"Myopia","Astigmatism","2025-09-29",{"date":52,"type":28},"2025-10-02",{"date":54,"type":28},"2025-08-28",{"date":56,"type":19},"2026-09-01",{"name":34,"class":35},""]